Plain-English translation of NCT07319442 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
CEDUR is a long-term registry — a carefully organized database — that collects health information from inflammatory bowel disease patients across Germany. Doctors and patients share medical details, treatment choices, and quality-of-life information over months and years. The goal is to understand how these diseases behave and which treatments work best for different people in everyday practice.
Doctors need better information about how inflammatory bowel disease progresses and responds to treatment when patients are cared for in real-world medical practices. This registry helps researchers and healthcare systems understand what actually works, how costs compare, and how to improve care quality for people living with these conditions.
You likely qualify if…
You likely don't qualify if…
You would work with your doctor to share your medical information, treatment details, and how the disease affects your daily life — all recorded securely online. You would also complete surveys about your quality of life and symptoms at regular intervals. There are no experimental drugs or invasive procedures; you simply allow your real-world health information to be collected and studied as part of a large German database.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Germany
Sponsor
ImmunoRegister gUG
Enrollment target
~10,000 participants
Started
May 2018
Primary completion
May 2036
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Stefanie Howaldt, MD
ImmunoRegister gUG
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.